Chemical regulation of secondary-metabolite synthesis was investigated through the improvement of poly-3-hydroxybutyrate (PHB) production in transgenic tobacco plants by the use of enzyme inhibitors. Two tobacco lines, BC3 and rCAB8, that produce PHB in both the cytosol and plastids were used. An acetyl-CoA carboxylase inhibitor, D-(＋)-Quizalofop-ethyl, increased PHB accumulation in both lines 2-fold. The accumulation rate of plastidial PHB in the rCAB8 line was 2.5-fold higher than that of cytosolic PHB in the BC3 line. A speciˆc inhibitor of 3-hydroxy-3-methylglutarylCoA reductase, mevastatin, also increased PHB accumulation but only in the BC3 line. These results indicated that chemical regulation of the native metabolic ‰ows by the speciˆc enzyme inhibitors increased secondary-metabolite production in the transgenic tobacco plants we used.
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Key words: ACCase; HMG-CoA reductase; poly-3-hydroxybutyrate; Quizalofop; mevastatin Recent progress in metabolic engineering allows the rapid generation of transgenic plants. In place of classic breeding by crossing and selection, this technique is used for breeding crop plants with improved product quantity and quality, 1) and heightened tolerance toward pests, environmental stresses, and chemicals, among other things. In particular, a system for agronomic mass production of new products in these plants is attractive because it uses only the energy of photosynthesis. On the basis of this perspective, extensive studies have been done to generate transgenic plants that produce the biodegradable polymers called poly-3-hydroxyalkanoates (PHAs).
2) Poly-3-hydroxybutyrate (PHB) is the most widespread homopolyester, composed of R-(")-3-hydroxybutyric acid units, 3) of the family of PHAs that various bacteria produce intracellularly from sugars and oils and use for energy storage. This bacterial metabolic pathway was introduced into a number of plants: Arabidopsis thaliana, [4] [5] [6] [7] cotton, 8) tobacco, 9, 10) and Brassica napus. 7, 11) Of these plants, the rate of PHA accumulation is high in oilseeds of B. napus 7, 11) and A. thaliana.
6) However, plants producing much PHA sometimes are sterile and have severe growth suppression, 6) indicating that the pathway introduced must be properly controlled.
The purpose of our research was to establish a novel method for improving PHB production in transgenic plants. A few methods for increasing PHB and PHA production have been demonstrated. One is with speciˆc promoters, 6, 7, 12) and the other is by feeding of substrate precursors 13) such as fatty acids and their ester conjugates. Our strategy is to increase the amount of substrate supplied to the PHB synthetic pathway by the use of chemicals such as speciˆc enzyme inhibitors.
For biosynthesis of PHB, three enzymes are needed: b-ketothiolase (BKTase), acetoacetyl-CoA reductase, and PHA synthase (Fig. 1) . BKTase converts two molecules of acetyl-CoA to acetoacetyl-CoA, which is then reduced to (R )-3-hydroxybutyryl-CoA by acetoacetyl-CoA reductase, andˆnally PHA synthase polymerizes the monomer to form PHB. The supply of acetyl-CoA is the largest factor for increased PHB accumulation. Acetyl-CoA, however, also is a key precursor for syntheses of essential plant constituents: cytosolic acetyl-CoA ‰ows not only into ‰avonoid synthesis but also into isoprenoid synthesis, and plastidial acetyl-CoA ‰ows into fatty acid synthesis. Therefore, there are basically two possible methods for changing acetyl-CoA ‰ow into PHB synthesis: 1) by speciˆc suppression of the competing, native acetyl-CoA metabolic pathways and 2) by speciˆc activation of only the PHB synthetic pathway introduced. We used the former method; when en- Tobacco Lines BC3 and rCAB8. The BC3 line produces PHB in the cytosol, and rCAB8 produces it in the plastids. Black and gray arrows are for the new PHB biosynthetic pathways, and white arrows are for the native acetyl-CoA metabolic pathways. Crossed-outs are for target sites of the inhibitors we used in this study. A; BKTase, B; Acetoacetyl-CoA reductase, C; PHA synthase. zyme inhibitors can speciˆcally suppress these native acetyl-CoA pathways, all or part of the unused acetyl-CoA will ‰ow into the appropriate PHB synthetic pathway, increasing PHB accumulation. Of the enzymes involved in native acetyl-CoA pathways, we selected acetyl-CoA carboxylase (ACCase) as the target enzyme because it is present in both the cytosol and plastids of plants, and because speciˆc suppression of its activity probably will directly increase the ‰ow of acetyl-CoA into PHB synthesis. Inhibition of the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) involved in the mevalonic acid (MVA) synthetic pathway of the cytosol also may increase PHB accumulation when unused acetoacetylCoA for mevalonate synthesis ‰ows into PHB synthesis. Such chemical regulation of secondarymetabolite synthesis, regardless of its occurrence in transgenic or nontransgenic plants, has not been reported in detail. An experimental system for redirecting the metabolic ‰ow with an enzyme inhibitor in tobacco plants has been very recently established by Saindrenan et al. 14) That is, treatment of piperonylic acid that is an eŠective inhibitor of transcinnamate-4-hydroxylase can redirect the metabolic ‰ow of trans-cinnamic acid from the main phenylpropanoid pathway into the benzoic acid and salicylic acid biosynthetic branch.
We used here two transgenic tobacco lines that produce PHB, BC3 and rCAB8, 9, 10) that we recently generated. The BC3 line produces PHB in the cytosol, and the rCAB8 line produces it in the plastids. In the rCAB8 line, the above three enzymes are all targeted to the plastids, 15) and in the BC3 line, acetoacetyl-CoA reductase and PHA synthase are expressed in the cytosol. The dimerization of acetylCoA in the BC3 line is catalyzed by an endogenous BKTase involved in cytosolic mevalonate synthesis. These introduced pathways, which are all controlled by the cauli‰ower mosaic virus 35S promoter, are always functional.
We found here that the use of enzyme inhibitors increased PHB accumulation in transgenic tobacco plants.
Materials and Methods
Chemicals. D-(+)-Quizalofop-ethyl (Quizalofop) was a gift from Nissan Chemical Co., Ltd. Ethyl D,L-3-hydroxyisoheptanoate was prepared by the Riformafsky reaction with isovaleraldehyde and ethyl bromoacetate. 16) Ethyl D,L-3-hydroxybutyrate was purchased from Pfaltz & Bauer Inc., and bacterial PHB and mevastatin were purchased from Sigma.
Plant materials and inhibitor treatment. Two transgenic tobacco plants (T2) of BC3 and rCBA8 lines, produced from Nicotiana tobaccum cv. Samsun NN by Agrobacterium-mediated transformations with the bacterial PHB biosynthetic genes, were grown in a green house at 259 C. Quizalofop or mevastatin was sprayed onˆve-leaf-stage plants that had grown for about 45 days after germination. Fifty milliliter of aqueous Quizalofop or mevastatin solution, both containing 10z MeOH (v W v), was used for treatment ofˆve plants once a week. Three leaves of the third to theˆfth rank or two leaves of the third and the fouth rank were collected and stored after being dried at 509 C for 24 h until being assayed for PHB.
Extraction and analysis of PHB. Extraction and analysis of PHB were done as described previously 9) with modiˆcations. The lyophilized leaves were powdered with mortar and pestle and PHB was extracted with chloroform (about 300 ml) for 24 h after the powdered leaves were washed with methanol (about 300 ml) for 12 h, with a Soxhlet apparatus. Ethanolysis was done with the chloroform extract corresponding to 5 to 10 mg (dry weight) of the leaves. A mixture of PHB extract or bacterial PHB, CHCl 3 (250 ml), conc. HCl (100 ml), and ethanol (850 ml) was heated at 1009 C for 4 h. After the mixture was cooled, ethyl 3-hydroxyisohexanoate (1 mg) as the external standard and 0.65 N NaOH in 0.9 M NaCl (1.7 ml) for neutralization were added, and the whole was mixed with a Vortex mixer for 1 min. The CHCl3 layer was removed and the residue was extracted with CHCl3 (200 ml). The combined CHCl3 extract (about 500 ml) was washed with 0.9 M NaCl (200 ml) and analyzed by GC-MS with a gas chromatograph (GC-17A, Shimadzu) with an HP-5MS column (0.25 mm ×30 m, Agilent Technologies) coupled to a mass spectrometer (GC-MS-QP5050A, Shimadzu). Peaks were detected in the selected ion mode by monitoring of a fragment ion, m W z 117, observed in both ethyl 3-hydroxybutyrate produced by ethanolysis of PHB and ethyl 3-hydroxyisohexanoate, the external standard. The calibration was done with the ethanolysis product of the puriˆed bacterial PHB.
Protein analysis. Crude proteins for immunoblot analyses and enzyme-activity assays were prepared from the leaves by the methods of Nakashita et al.
9)
The immunoblot analyses, with antibodies produced in a rabbit against a partial polypeptide of PHA synthase as the probe, were done as described previously. 9) Activities of BKTase and acetoacetyl-CoA reductase were assayed as described previously by Nishimura et al., 17) and Nakashita et al. 9) respectively. The protein concentration was measured by the Bradford assay with bovine serum alubumin as a standard.
Results and Discussion

EŠects of ACCase inhibitor Quizalofop on PHB accumulation
Quizalofop and its related herbicides have been used for selective control of gramineous weeds.
18) The actions of these herbicides are arise from the plastidial ACCase of Gramineae, 19) such as rice and wheat. Figure 2A shows the PHB content ( mg W g dry weight) and leaf growth (g dry weight) in BC3 plants grown for 2 weeks after theˆrst treatment of Quizalofop. The Quizalofop concentrations used were 2, 10, and 50 mM. The leaf dry weights increased during the 2 weeks, but the increase was independent of the Quizalofop concentration. Quizalofop-treated plants had more PHB than the untreated plants. The increase was about 170z for all concentrations of Quizalofop tested compared with the value for untreated plants, taken to be 100z. Figure 2B shows the eŠects of Quizalofop on PHB accumulation in the rCAB8 line. Experiments were done under the same conditions as for the BC3 line, except that the Quizalofop concentration was 10, 50 and 250 mM. After the 2 weeks of Quizalofop treatment, both leaf growth and, unexpectedly, the PHB content changed in the similar patterns as with the other line. The increase in PHB was about 150z for 50 mM Quizalofop compared with the untreated plants.
Quizalofop increased PHB in both lines. The concentrations of Quizalofop needed for increasing PHB diŠered for the two lines. The concentration of 2 mM was enough for the BC3 line, but 50 mM was needed for the rCAB8 line.
EŠects of Quizalofop on activation of PHB synthetic pathways
There are two probable mechanisms for this increase of PHB accumulation by Quizalofop: 1) increase of the acetyl-CoA supply and 2) speciˆc activation of PHB synthetic pathways. Probably increase in PHB accumulation by Quizalofop in the BC3 line is due to suppression of the activity of ACCase, because the target site of Quizalofop is a slightly susceptible, eukaryote-form cytosolic ACCase. The unexpected increase in the rCAB8, however, cannot be explained by the suppression of a plastidial, tolerant ACCase. In an examination of the mechanism for the BC3 line, the levels of the PHB- synthesizing enzymes were compared between Quizalofop-treated and untreated plants. PHA synthase was analyzed by an immunoblot assay. The crude protein extract for the immunoblot assay was prepared from the leaves of 2-week-treated plants: the Quizalofop concentrations used for treatment were 10 mM in the BC3 line and 50 mM in the rCAB8 line. Figure 3 shows immunoblots of the PHA synthase. In both lines, the relative PHA synthase levels detected were not higher in the treated plants than in the untreated plants.
The relative activities of BKTases and acetoacetylCoA reductase were compared by enzyme-activity assays. The BKTase activity measured is derived from only the endogenous BKTase in the BC3 line and from the introduced enzyme and the BKTase in the rCAB8 line. In these experiments, no signiˆcant diŠerences in the enzymatic activities of both BKTases and acetoacetyl-CoA reductase were observed (not shown). These results showed that Quizalofop activates neither of the PHB synthetic enzymes including the endogenous BKTase in either line. Therefore, we deduce that the increase of PHB production by Quizalofop in both lines is due to an increase in the acetyl-CoA supply, and not to the speciˆc activation of PHB synthetic enzymes. We speculate that the suppression of the cytosolic, slightly susceptible ACCase by Quizalofop for the BC3 line increases the acetyl-CoA supply.
EŠects of Quizalofop on PHB accumulation rate
To discover when the PHB is produced in these transgenic plants, time-course experiments were done. Figure 4 (A and B) shows the PHB contents and leaf dry weights in the one-and two-week-old plants after treatment. The Quizalofop concentrations used were 10 mM in the BC3 line and 50 mM in the rCAB8 line. Changes in the leaf dry weight (line graphs in A and B) and the PHB content (bar graphs in A and B) were similar for the two lines. Considering the change in leaf dry weights, theˆrst one-week period in which the weight increased rapidly could be regarded as the leaf-expanding stage and the following one-week period in which the weight increased gradually could be regarded as the leaf-maturation stage. The relative PHB contents increased in both treated and untreated plants, with progress from the expanding to the maturation stage. Increases in the PHB content with Quizalofop treatment were already observed in theˆrst one-week period: about 150z in the BC3 line and about 120z in the rCAB8 line. These rates further increased to about 170z in the BC3 line and about 150z in the rCAB8 line after the next one-week period. Figure 4C shows a modiˆed graph of the mean values of these PHB levels in the two lines. The coe‹cient of determination, R 2 , was high when linear relationships wereˆtted. These linear relationships indicate that the PHB production rates were all constant, regardless of treatment or untreatment. That is, in both lines, the production rates did not change during the two-week period, although the leaf growth rate changed at the expanding stage. From the slopes, relative PHB production rates were estimated. The rates were twofold in the treated plants compared with the untreated plants. This analysis also showed that the relative PHB production rate in the plastids was constant at 2.5-fold higher than that in the cytosol. These results indicate that the metabolism of acetyl-CoA in plants also did not change from the leaf-expanding stage to the maturation stage, and that continuous treatment with the inhibitor was eŠective in increasing the acetyl-CoA supply.
EŠects of HMGR inhibitor, mevastatin, on PHB accumulation
Mevastatin speciˆcally suppressed HMGR in the cytosol and inhibits MVA synthesis 20) (Fig. 1) . In rCAB8 line, an increase of PHB accumulation by mavastatin treatment was not expected because the target enzyme is not present in the plastids. Figure 5 shows the PHB contents in BC3 line (A), together with those in rCAB8 line (B) as a control, both of which were grown for 2 weeks after mevastatin treatment. The range of concentrations of mevastatin used in the spray was from 0.1 to 10 mM in both lines. Little if any growth inhibition was observed at these concentrations; dry weights (line graphs) of each line rapidly increased during the 2-week period after the treatment. Under these growth conditions, mevastatin increased the PHB accumulation only in BC3 line. The maximum rate increase was 192z of the control for 1 mM mevastatin (bar graphs). However, at a higher concentration, 10 mM, PHB accumulation was suppressed. In rCAB8 line, the increase in PHB, as expected, was low. These results show that the speciˆc inhibition of the target enzyme HMGR by mevastatin caused an increase of the acetoacetylCoA supply for PHB synthesis, causing an increase in PHB production.
Bacterial PHA is not only biodegradable but also has diverse physical properties ranging from those of stiŠ plastics to those of soft elastomers, depending on the size of the monomer units (C4 to C16). Its biodegradability allows PHA to be considered as a renewable and environmentally friendly polymer. High-PHA-producing bacteria have been isolated, but bacterial PHA is still more expensive than synthetic polymers. A system for producing PHA with transgenic plants may reduce the cost of PHA production. Classic plant-breeding methods and transgenic techniques have been used to increase productivity and to obtain useful metabolites. Here, we improved PHB production in transgenic plants through chemical regulation of the metabolic pathways: the application of speciˆc enzyme inhibitors increased PHB accumulation in our transgenic tobacco plants that produce PHB in the cytosol or plastids. Such the chemical regulation of the metabolic ‰ow with enzyme inhibitors is a potent strategy for the control of plant metabolism. High-PHB-producing plants may not necessarily be suitable for the manufacture of PHB because they have severe growth suppression and sterility, reducing both growth rate and total plant mass. The chemical regulation method that we established in this study might overcome these problems with high-PHB-producing plants. When su‹ciently mature PHB-producing plants that do not have growth suppression are treated with Quizalofop or mevastatin, they may produce much PHB.
The proposed mechanisms by which application of Quizalofop and mevastatin increases PHB accumulation in the BC3 line can be tested through comparisons of levels of acetyl-CoA and ‰avonoids, and of acetoacetyl-CoA and isoprenoids, between the plants treated with inhibitor or not.
